Characterization of Prognostic Factors and Efficacy in a Phase-II Study with Docetaxel and Estramustine for Advanced Hormone Refractory Prostate Cancer
Year: 2005
Type: article
Study design: Clinical Trial
Source: Oncology Research and Treatment
DOI: 10.1159/000088297
Institution: Otto-von-Guericke-Universität Magdeburg
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2059980332
